These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38451282)

  • 1. Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na
    Du CM; Leu WJ; Jiang YH; Chan SH; Chen IS; Chang HS; Hsu LC; Hsu JL; Guh JH
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6533-6550. PubMed ID: 38451282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epi-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma.
    Hsu JL; Liu FL; Hsu LC; Chang HS; Leu WJ; Yu CC; Chang WL; Chen IS; Kung FL; Guh JH
    Oncotarget; 2015 Sep; 6(27):24032-46. PubMed ID: 26125228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na⁺/K⁺-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades.
    Chan SH; Leu WJ; Hsu LC; Chang HS; Hwang TL; Chen IS; Chen CS; Guh JH
    Biochem Pharmacol; 2013 Dec; 86(11):1564-75. PubMed ID: 24099795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na
    Leu WJ; Wang CT; Hsu JL; Chen IS; Chang HS; Guh JH
    Prostate; 2020 Mar; 80(4):305-318. PubMed ID: 31905252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of glucoevatromonoside alone and in combination with chemotherapy drugs and their effects on Na
    Schneider NFZ; Menegaz D; Dagostin ALA; Persich L; Rocha SC; Ramos ACP; Cortes VF; Fontes CFL; de Pádua RM; Munkert J; Kreis W; Braga FC; Barbosa LA; Silva FRMB; Simões CMO
    Mol Cell Biochem; 2021 Apr; 476(4):1825-1848. PubMed ID: 33459980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
    Leu WJ; Chang HS; Chan SH; Hsu JL; Yu CC; Hsu LC; Chen IS; Guh JH
    PLoS One; 2014; 9(1):e87323. PubMed ID: 24475272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and cytostatic effects of digitoxigenin monodigitoxoside (DGX) in human lung cancer cells and its link to Na,K-ATPase.
    Schneider NFZ; Persich L; Rocha SC; Ramos ACP; Cortes VF; Silva IT; Munkert J; Pádua RM; Kreis W; Taranto AG; Barbosa LA; Braga FC; Simões CMO
    Biomed Pharmacother; 2018 Jan; 97():684-696. PubMed ID: 29101813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of the cardenolide convallatoxin and its Na,K-ATPase regulation.
    Schneider NFZ; Silva IT; Persich L; de Carvalho A; Rocha SC; Marostica L; Ramos ACP; Taranto AG; Pádua RM; Kreis W; Barbosa LA; Braga FC; Simões CMO
    Mol Cell Biochem; 2017 Apr; 428(1-2):23-39. PubMed ID: 28176244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers.
    Mijatovic T; Roland I; Van Quaquebeke E; Nilsson B; Mathieu A; Van Vynckt F; Darro F; Blanco G; Facchini V; Kiss R
    J Pathol; 2007 Jun; 212(2):170-9. PubMed ID: 17471453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A steroidal Na+/K+ ATPase inhibitor triggers pro-apoptotic signaling and induces apoptosis in prostate and lung tumor cells.
    Honisch S; Alkahtani S; Kounenidakis M; Liu G; Alarifi S; Al-Yahya H; Dimas K; AlKahtane AA; Prousis KC; Al-Dahmash B; Calogeropoulou T; Alevizopoulos K; Lang F; Stournaras C
    Anticancer Agents Med Chem; 2014; 14(8):1161-8. PubMed ID: 24942548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations.
    Park IH; Kim JY; Jung JI; Han JY
    Invest New Drugs; 2010 Dec; 28(6):791-9. PubMed ID: 19760159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/ERK Signaling Pathway.
    Zhang Y; Liu H; Liu X; Lang L
    Discov Med; 2024 Apr; 36(183):836-841. PubMed ID: 38665031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
    Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
    Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC.
    Xia X; Liu Y; Liao Y; Guo Z; Huang C; Zhang F; Jiang L; Wang X; Liu J; Huang H
    Eur J Pharmacol; 2019 Aug; 856():172409. PubMed ID: 31132355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
    Sun C; Gao W; Liu J; Cheng H; Hao J
    Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na
    Silva IT; Munkert J; Nolte E; Schneider NFZ; Rocha SC; Ramos ACP; Kreis W; Braga FC; de Pádua RM; Taranto AG; Cortes V; Barbosa LA; Wach S; Taubert H; Simões CMO
    Biomed Pharmacother; 2018 Nov; 107():464-474. PubMed ID: 30107342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targets.
    Yang P; Menter DG; Cartwright C; Chan D; Dixon S; Suraokar M; Mendoza G; Llansa N; Newman RA
    Mol Cancer Ther; 2009 Aug; 8(8):2319-28. PubMed ID: 19671733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inhibition of c-MET by podophyllotoxin promotes caspase-dependent apoptosis and suppresses cell growth in gefitinib-resistant non-small cell lung cancer cells.
    Oh HN; Kwak AW; Lee MH; Kim E; Yoon G; Cho SS; Liu K; Chae JI; Shim JH
    Phytomedicine; 2021 Jan; 80():153355. PubMed ID: 33039730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.
    Lee JY; Lee YM; Chang GC; Yu SL; Hsieh WY; Chen JJ; Chen HW; Yang PC
    PLoS One; 2011; 6(8):e23756. PubMed ID: 21858220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway.
    Wang MS; Han QS; Jia ZR; Chen CS; Qiao C; Liu QQ; Zhang YM; Wang KW; Wang J; Xiao K; Ding XS
    Acta Pharmacol Sin; 2022 Jan; 43(1):167-176. PubMed ID: 33772142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.